Phase II trial of neoadjuvant docetaxel and carboplatin with filgrastim (G-CSF) support in patients with locally advanced breast cancer.

被引：0
|
作者：
Karmarkar, S [1 ]
Jones, D [1 ]
Hatch, S [1 ]
Klementich, F [1 ]
Ansari, K [1 ]
Grube, B [1 ]
Chao, C [1 ]
Townsend, C [1 ]
机构：
[1] Univ Texas, Med Branch, Galveston, TX 77550 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
789
引用
收藏
页码：74S / 74S
页数：1
相关论文
共 50 条
  • [1] Phase II trial of neoadjuvant docetaxel with or without bevacizumab in patients with locally advanced breast cancer.
    Overmoyer, B
    Silverman, P
    Leeming, R
    Shenk, R
    Lyons, J
    Ziats, N
    Jesberger, J
    Dumadag, L
    Remick, S
    Chen, H
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 58S - 58S
  • [2] Phase II trial of neoadjuvant docetaxel with or without bevacizumab in patients with locally advanced breast cancer.
    Overmoyer, B
    Silverman, P
    Leeming, R
    Shenk, R
    Lyons, J
    Jesberger, J
    Hartman, P
    Dumadag, L
    Chen, H
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S106 - S106
  • [3] Phase II study of dose-dense doxorubicin and docetaxel as neoadjuvant chemotherapy with G-CSF support in patients with large or locally advanced breast cancer
    Jesús García-Mata
    Andrés García-Palomo
    Lourdes Calvo
    Ramón Mel
    Juan Jesús Cruz
    Manuel Ramos
    Clinical and Translational Oncology, 2008, 10 : 739 - 744
  • [4] Phase II study of dose-dense doxorubicin and docetaxel as neoadjuvant chemotherapy with G-CSF support in patients with large or locally advanced breast cancer
    Garcia-Mata, Jesus
    Garcia-Palomo, Andres
    Calvo, Lourdes
    Mel, Ramon
    Cruz, Juan Jesus
    Ramos, Manuel
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2008, 10 (11): : 739 - 744
  • [5] A phase II trial of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer.
    Lu, YS
    Kuo, SH
    Su, WP
    Yang, CH
    Hsu, C
    Yang, TL
    Huang, CS
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 93S - 93S
  • [6] A phase II trial of Neoadjuvant docetaxel and capecitabine for locally advanced breast cancer
    Lebowitz, PF
    Eng-Wong, J
    Swain, SM
    Berman, A
    Merino, MJ
    Chow, CK
    Venzon, D
    Zia, F
    Danforth, D
    Liu, E
    Zujewski, J
    CLINICAL CANCER RESEARCH, 2004, 10 (20) : 6764 - 6769
  • [7] Phase I/II study of alternating docetaxel and mitoxantrone with G-CSF support in advanced breast cancer (ABC)
    Kourousis, C
    Androulakis, N
    Kakolyris, S
    Heras, P
    Vardakis, N
    Kotsakis, A
    Kalbakis, C
    Meramveliotakis, N
    Hatzidaki, D
    Samonis, G
    Georgoulias, V
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 682 - 682
  • [8] Intensive weekly chemotherapy with docetaxel, epirubicin and carboplatin with G-CSF support in patients with advanced gastric cancer
    Makatsoris, Thomas
    Papakostas, Pavlos
    Kalofonos, Haralahos P.
    Xanthakis, Loannis
    Tsavdaridis, Dimitrios
    Aravantinos, Gerasimos
    Gogas, Helen
    Klouvas, George
    Kosmidis, Paris
    Pectasides, Dimitrios
    Fountzilas, George
    MEDICAL ONCOLOGY, 2007, 24 (03) : 301 - 307
  • [9] Phase II study of neoadjuvant therapy with epirubicin and docetaxel for women with locally advanced breast cancer.
    Holter, JL
    Tfayli, A
    Venkattapa, S
    Bova, A
    Howard, O
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 98S - 98S
  • [10] Neoadjuvant carboplatin and docetaxel in locally advanced triple negative breast cancer: A Hispanic trial
    Gomez, Saul Campos
    Gomez, Karen Angelica Campos
    Garces, Marciela Garcia
    Morelos, Gladys
    Alvarez, Jesus Hernandez
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345